Abstract
We report the case of a 15-year-old boy with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). He presented with diplopia and ataxia and his cerebrospinal fluid showed mild pleocytosis and elevated protein. MRI demonstrated a reversible splenial lesion in the corpus callosum. He did not receive any treatment and recovered quickly within two weeks. Results of neurological examination after 3 months were completely normal. MERS is relatively unknown in Europe. The majority of patients are reported in East Asia. This post-infectious encephalitis/encephalopathy arises soon after the onset of symptoms. The prognosis is excellent and most patients recover completely without neurological sequelae. MRI typically shows a reversible splenial lesion with diffusion restriction and without contrast enhancement, sometimes with adjacent symmetrical lesions extending into the subcortical white matter. The pathogenesis is still unknown. Recognition of the condition and its clinic-radiological discrimination from acute disseminated encephalomyelitis may prevent unnecessary treatment.
Highlights
Mild encephalitis/encephalopathy with reversible splenial lesions (MERS) in children is a rather unknown disease entity in Europe
We report the case of a 15-year-old boy with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS)
magnetic resonance imaging (MRI) typically shows a reversible splenial lesion with diffusion restriction and without contrast enhancement, sometimes with adjacent symmetrical lesions extending into the subcortical white matter
Summary
Mild encephalitis/encephalopathy with reversible splenial lesions (MERS) in children is a rather unknown disease entity in Europe. In 2002, Kobata et al was the first to describe a reversible lesion in the splenium of the corpus callosum (SCC) on magnetic resonance imaging (MRI) in a child with rotavirus encephalopathy [1]. MERS is described most often in patients with influenza-associated encephalitis/encephalopathy and the incidence is much higher in patients of East Asian origin [2, 3, 4]. MERS was only described in 15 children outside East Asia, one of them of Indian origin [3, 5, 7, 8, 9, 10, 11, 12]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the International Child Neurology Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.